The complex Cbfa1/Runx2 gene gives rise to two isoforms, Runx2-II and Runx2-I, respectively derived from the distal """"""""bone-related"""""""" (P1) and proximal (P2) promoters. Except for differences in their 5' untranslated regions (5'UTRs) and N-termini, the Type II and I Cbfa1 gene products are identical. The molecular mechanisms whereby these isoforms impart differential function to developmental pathways involving osteogenesis, chondrogenesis, and odontogenesis remain to be defined, but are likely derived from distinct N-terminal functional domains and possibly differential expression imparted by the ability of their 5'UTRs to modulate translational efficiency. Distinct function of the Runx2-II II N-terminal isoform is suggested by its later expression during bone development, but prior transgenic studies that deleted both isoforms were not designed to evaluate their separate function, in addition, the Runx2 gene generates multiple mRNAs with 5'UTRs having complex secondary structures that regulate translation in vitro through internal ribosome entry site (IRES) initiation of protein synthesis. The overall goals of these investigations are to establish the distinct function of Runx2-II and Runx2-I isoforms and to confirm that IRES-dependent translation control plays an important role in regulating its expression and tissue specific functions in vivo.
In aim 1, we will determine the separate function of the """"""""bone-related"""""""" isoform by completing the characterization of mice selectively deficient in the Runx2-II isoform. In addition, we will create a selective Runx2-I null mouse that leaves the expression and function of the Runx2-II isoform intact.
In aim 2, we will investigate the ability of the 5'UTRs of Type I and Il Cbfa1 to regulate translation efficiency through cap-and IRES-dependent mechanisms in vitro and in transgenic mice. These studies will define the unique functions of the N-terminal domains, and determine if translational regulation contributes to the tissue-specific expression of Runx2-I and Runx2-II isoforms.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
5R01AR049712-06
Application #
7106433
Study Section
Oral Biology and Medicine Subcommittee 1 (OBM)
Program Officer
Sharrock, William J
Project Start
2003-09-30
Project End
2008-06-30
Budget Start
2006-07-01
Budget End
2007-06-30
Support Year
6
Fiscal Year
2006
Total Cost
$321,183
Indirect Cost
Name
University of Kansas
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
016060860
City
Kansas City
State
KS
Country
United States
Zip Code
66160
Xiao, Zhousheng; Quarles, Leigh Darryl (2015) Physiological mechanisms and therapeutic potential of bone mechanosensing. Rev Endocr Metab Disord 16:115-29
Xiao, Zhousheng; Cao, Li; Liang, Yingjuan et al. (2014) Osteoblast-specific deletion of Pkd2 leads to low-turnover osteopenia and reduced bone marrow adiposity. PLoS One 9:e114198
He, Nan; Xiao, Zhousheng; Yin, Tong et al. (2011) Inducible expression of Runx2 results in multiorgan abnormalities in mice. J Cell Biochem 112:653-65
Xiao, Zhousheng; Zhang, Shiqin; Cao, Li et al. (2010) Conditional disruption of Pkd1 in osteoblasts results in osteopenia due to direct impairment of bone formation. J Biol Chem 285:1177-87
Xiao, Z S; Quarles, L D (2010) Role of the polycytin-primary cilia complex in bone development and mechanosensing. Ann N Y Acad Sci 1192:410-21
Zhang, Shiqin; Xiao, Zhousheng; Luo, Junming et al. (2009) Dose-dependent effects of Runx2 on bone development. J Bone Miner Res 24:1889-904
Li, Yalin; Pan, Wei; Xu, Wanfeng et al. (2009) RUNX2 mutations in Chinese patients with cleidocranial dysplasia. Mutagenesis 24:425-31
Liao, Qing-Chuan; Li, Ya-Lin; Qin, Yan-Fang et al. (2008) Inhibition of adipocyte differentiation by phytoestrogen genistein through a potential downregulation of extracellular signal-regulated kinases 1/2 activity. J Cell Biochem 104:1853-64
Xiao, Zhousheng; Zhang, Shiqin; Magenheimer, Brenda S et al. (2008) Polycystin-1 regulates skeletogenesis through stimulation of the osteoblast-specific transcription factor RUNX2-II. J Biol Chem 283:12624-34
Li, Yalin; Zhang, Wei; Guo, Dong et al. (2008) Pharmacokinetics of the new proton pump inhibitor ilaprazole in Chinese healthy subjects in relation to CYP3A5 and CYP2C19 genotypes. Clin Chim Acta 391:60-7

Showing the most recent 10 out of 16 publications